SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon informs about newspaper advertisement

23 Mar 2024 Evaluate

Further to its letter dated March 21, 2024 regarding intimation of Postal Ballot Notice, and in compliance with the provisions of Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Biocon has informed that it enclosed copies of newspaper advertisement published in Financial Express (English Language – All India Edition) and Vijayavani, (Kannada Language – Bengaluru Edition) on March 22, 2024 with regard to Postal Ballot Notice and Remote e-voting. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×